Jeffrey A Mills (Jeffrey Strawn, Jeffrey R Strawn)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 60

Top Topics

Randomized Controlled Trial

Bipolar Disorder

Top Venues

Journal of child and adolescent psychopharmacology

Clinical pharmacology and therapeutics

Depression and anxiety

This page only lists publications with an associated author ORCID identifier.

Publications

Duncan C Honeycutt, Thomas J Blom, Laura B Ramsey, Jeffrey A Mills, Kaitlyn M Bruns, Jeffrey A Welge, Luis Rodrigo Patino Duran, Manpreet K Singh, Melissa P DelBello
Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Duncan C Honeycutt, Thomas J Blom, Laura B Ramsey, Jeffrey A Mills, Kaitlyn M Bruns, Jeffrey A Welge, Luis Rodrigo Patino Duran, Manpreet K Singh, Melissa P DelBello
Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Salma Malik, Pragya Verma, Gualberto Ruaño, Areej Al Siaghy, Azwa Dilawar, Jeffrey R Bishop, Jeffrey A Mills, Lisa B Namerow
Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications. Journal of child and adolescent psychopharmacology 34 (1) (2024)
W Thomas Baumel, Ethan A Poweleit, Zoe Neptune, Heidi K Schroeder, Laura B Ramsey, Jeffrey Mills, Jeffrey A Mills
Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta, Judith W Dexheimer, Jeffrey A Mills, Laura B Ramsey
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents. Clinical pharmacology and therapeutics 115 (4) (2024)
W Thomas Baumel, Ethan A Poweleit, Zoe Neptune, Heidi K Schroeder, Laura B Ramsey, Jeffrey Mills, Jeffrey A Mills
Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta, Judith W Dexheimer, Jeffrey A Mills, Laura B Ramsey
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents. Clinical pharmacology and therapeutics 115 (4) (2024)
Jeffrey A Mills, Jeffrey A Mills
Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder". Journal of child and adolescent psychopharmacology 34 (2) (2024)
Salma Malik, Pragya Verma, Gualberto Ruaño, Areej Al Siaghy, Azwa Dilawar, Jeffrey R Bishop, Jeffrey A Mills, Lisa B Namerow
Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Jenni E Farrow, Thomas J Blom, Wan Y Kwok, Kaitlyn E Hardesty, Jeffrey A Mills, Melissa P DelBello
Prevalence and Correlates of Eating Disorder Symptoms in Adolescents with Bipolar I Disorder. Journal of child and adolescent psychopharmacology (2024)
Jeffrey A Mills, Jeffrey A Mills
Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder". Journal of child and adolescent psychopharmacology 34 (2) (2024)
Eric M Mendez, Jeffrey A Mills, Vikram Suresh, Julia N Stimpfl, Jeffrey A Mills
Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines. CNS spectrums 29 (3) (2024)
Jeffrey A Mills, Jeffrey A Mills
Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder". Journal of child and adolescent psychopharmacology (2024)
Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta, Judith W Dexheimer, Jeffrey A Mills, Laura B Ramsey
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents. Clinical pharmacology and therapeutics 115 (4) (2024)
Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta, Judith W Dexheimer, Jeffrey A Mills, Laura B Ramsey
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents. Clinical pharmacology and therapeutics 115 (4) (2024)
Jeffrey A Mills, Jeffrey A Mills
Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder". Journal of child and adolescent psychopharmacology 34 (2) (2024)
Stephani L Stancil, Tracy Sandritter, Jeffrey A Mills
Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B *15:02. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Stephani L Stancil, Tracy Sandritter, Jeffrey A Mills
Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B *15:02. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Stephani L Stancil, Tracy Sandritter, Jeffrey A Mills
Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B *15:02. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Stephani L Stancil, Tracy Sandritter, Jeffrey A Mills
Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B *15:02. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Eric M Mendez, Jeffrey A Mills, Vikram Suresh, Julia N Stimpfl, Jeffrey A Mills
Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines. CNS spectrums 29 (3) (2024)
Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta, Judith W Dexheimer, Jeffrey A Mills, Laura B Ramsey
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects with Pharmacokinetic Data in Children and Adolescents. Clinical pharmacology and therapeutics (2024)
Eric M Mendez, Jeffrey A Mills, Vikram Suresh, Julia N Stimpfl, Jeffrey A Mills
Trajectory and Magnitude of Response in Adults with Anxiety Disorders: A Bayesian Hierarchical Modeling Meta-Analysis of Selective Serotonin Reuptake Inhibitors, Serotonin Norepinephrine Reuptake Inhibitors and Benzodiazepines. CNS spectrums (2024)
Jenni E Farrow, Thomas J Blom, Wan Y Kwok, Kaitlyn E Hardesty, Jeffrey A Mills, Melissa P DelBello
Prevalence and Correlates of Eating Disorder Symptoms in Adolescents with Bipolar I Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Eric M Mendez, Jeffrey A Mills, Vikram Suresh, Julia N Stimpfl, Jeffrey A Mills
Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines. CNS spectrums (2024)
Jenni E Farrow, Thomas J Blom, Wan Y Kwok, Kaitlyn E Hardesty, Jeffrey A Mills, Melissa P DelBello
Prevalence and Correlates of Eating Disorder Symptoms in Adolescents with Bipolar I Disorder. Journal of child and adolescent psychopharmacology 34 (5) (2024)
Amarachi A Kanu, Michelle M Johnston, Ethan A Poweleit, Samuel E Vaughn, Jeffrey A Mills, Laura B Ramsey
Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta, Judith W Dexheimer, Jeffrey A Mills, Laura B Ramsey
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects with Pharmacokinetic Data in Children and Adolescents. Clinical pharmacology and therapeutics (2024)
Ethan A Poweleit, Samuel E Vaughn, Zeruesenay Desta, Judith W Dexheimer, Jeffrey A Mills, Laura B Ramsey
Machine Learning-Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents. Clinical pharmacology and therapeutics 115 (4) (2024)
W Thomas Baumel, Ethan A Poweleit, Zoe Neptune, Heidi K Schroeder, Laura B Ramsey, Jeffrey Mills, Jeffrey A Mills
Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Amarachi A Kanu, Michelle M Johnston, Ethan A Poweleit, Samuel E Vaughn, Jeffrey A Mills, Laura B Ramsey
Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Duncan C Honeycutt, Thomas J Blom, Laura B Ramsey, Jeffrey A Mills, Kaitlyn M Bruns, Jeffrey A Welge, Luis Rodrigo Patino Duran, Manpreet K Singh, Melissa P DelBello
Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Jeffrey A Mills, Eric Mendez, Jeffrey R Strawn
The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults. Journal of child and adolescent psychopharmacology (2024)
Jeffrey A Mills, Jeffrey A Mills, Ethan A Poweleit, Laura B Ramsey, Paul E Croarkin
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Pharmacotherapy (2023)
Melissa P DelBello, Kaitlyn M Bruns, Thomas Bloom, Luis Rodrigo Patino Duran, Jeffrey A Mills, Caleb M Adler, Jeffrey Welge
A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine. Journal of child and adolescent psychopharmacology (2023)
Eric M Mendez, Katherine K Dahlsgaard, John M Hjelmgren, Jeffrey A Mills, Vikram Suresh, Jeffrey A Mills
What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis. Journal of child and adolescent psychopharmacology (2023)
Jeffrey A Mills, Leslie Moldauer, Rebekah D Hahn, Alexandria Wise, Kristina Bertzos, Beth Eisenberg, Edward Greenberg, Chengcheng Liu, Mallika Gopalkrishnan, Molly McVoy, James A Knutson
A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder. Journal of child and adolescent psychopharmacology 33 (3) (2023)
Melissa P DelBello, Kaitlyn M Bruns, Thomas Bloom, Luis Rodrigo Patino Duran, Jeffrey A Mills, Caleb M Adler, Jeffrey Welge
A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine. Journal of child and adolescent psychopharmacology 33 (4) (2023)
W Thomas Baumel, Jeffrey A Mills, Heidi K Schroeder, Zoe Neptune, Amir Levine, Jeffrey A Mills
Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and Their Relationship to Selective Serotonin Reuptake Inhibitor Treatment or Placebo. Child psychiatry and human development (2023)
Melissa P DelBello, Kaitlyn M Bruns, Thomas Bloom, Luis Rodrigo Patino Duran, Jeffrey A Mills, Caleb M Adler, Jeffrey Welge
A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine. Journal of child and adolescent psychopharmacology 33 (4) (2023)
Melissa P DelBello, Kaitlyn M Bruns, Thomas Bloom, Luis Rodrigo Patino Duran, Jeffrey A Mills, Caleb M Adler, Jeffrey Welge
A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine. Journal of child and adolescent psychopharmacology 33 (4) (2023)
Jeffrey A Mills, Jeffrey A Mills, Ethan A Poweleit, Laura B Ramsey, Paul E Croarkin
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Pharmacotherapy (2023)
Jeffrey A Mills, Leslie Moldauer, Rebekah D Hahn, Alexandria Wise, Kristina Bertzos, Beth Eisenberg, Edward Greenberg, Chengcheng Liu, Mallika Gopalkrishnan, Molly McVoy, James A Knutson
A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder. Journal of child and adolescent psychopharmacology 33 (3) (2023)
Jeffrey A Mills, Leslie Moldauer, Rebekah D Hahn, Alexandria Wise, Kristina Bertzos, Beth Eisenberg, Edward Greenberg, Chengcheng Liu, Mallika Gopalkrishnan, Molly McVoy, James A Knutson
A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder. Journal of child and adolescent psychopharmacology 33 (3) (2023)
Chad A Bousman, James M Stevenson, Laura B Ramsey, Katrin Sangkuhl, J Kevin Hicks, Jeffrey A Mills, Ajeet B Singh, Gualberto Ruaño, Daniel J Mueller, Evangelia Eirini Tsermpini, Jacob T Brown, Gillian C Bell, James Steven Leeder, Andrea Gaedigk, Stuart A Scott, Teri E Klein, Kelly E Caudle, Jeffrey R Bishop
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants. Clinical pharmacology and therapeutics (2023)
Carl Y Zhang, Jennifer L Vande Voort, Deniz Yuruk, Jeffrey A Mills, Graham J Emslie, Betsy D Kennard, Taryn Mayes, Madhukar Trivedi, William V Bobo, Jeffrey A Mills, Arjun P Athreya, Paul E Croarkin
A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales. Journal of child and adolescent psychopharmacology 32 (5) (2022)
W Thomas Baumel, Jeffrey A Mills, Heidi K Schroeder, Ashley M Specht, Richard Rothenberg, Tara S Peris, Jeffrey A Mills
Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled Trial. Journal of child and adolescent psychopharmacology 32 (4) (2022)
Katelyn M Rossow, Samuel E Vaughn, Jeffrey A Mills, Sara L Van Driest, Laura B Ramsey
The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents. Pharmacogenomics 22 (8) (2021)
Jeffrey A Mills, Ethan A Poweleit, Jeffrey A Mills, Heidi K Schroeder, Zoe A Neptune, Ashley M Specht, Jenni E Farrow, Xue Zhang, Lisa J Martin, Laura B Ramsey
Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial. Journal of personalized medicine 11 (11) (2021)
Marissa J Luft, Eric T Dobson, Amir Levine, Paul E Croarkin, Jeffrey A Mills
Pharmacologic interventions for antidepressant-induced sexual dysfunction: a systematic review and network meta-analysis of trials using the Arizona sexual experience scale. CNS spectrums (2021)
Lu Lu, Hailong Li, William T Baumel, Jeffrey A Mills, Kim M Cecil, Heidi K Schroeder, Sarah A Mossman, Xiaoqi Huang, Qi-Yong Gong, John A Sweeney, Jeffrey A Mills
Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2021)
Luis Rodrigo Patino Duran, Christina C Klein, Jeffrey A Mills, Thomas J Blom, Maxwell J Tallman, Caleb M Adler, Jeffrey A Welge, Melissa P DelBello
A Randomized, Double-Blind, Controlled Trial of Lithium Versus Quetiapine for the Treatment of Acute Mania in Youth with Early Course Bipolar Disorder. Journal of child and adolescent psychopharmacology 31 (7) (2021)
Julia N Stimpfl, Jeffrey A Mills, Jeffrey A Mills
Pharmacologic predictors of benzodiazepine response trajectory in anxiety disorders: a Bayesian hierarchical modeling meta-analysis. CNS spectrums (2021)
Paul E Croarkin, Ahmed Z Elmaadawi, Scott T Aaronson, G Randolph Schrodt, Richard C Holbert, Sarah Verdoliva, Karen L Heart, Mark A Demitrack, Jeffrey A Mills
Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (2) (2020)
Laura B Ramsey, Jeffrey R Bishop, Jeffrey A Mills
Pharmacogenetics of treating pediatric anxiety and depression. Pharmacogenomics 20 (12) (2020)
Vikram Suresh, Jeffrey A Mills, Paul E Croarkin, Jeffrey A Mills
What next? A Bayesian hierarchical modeling re-examination of treatments for adolescents with selective serotonin reuptake inhibitor-resistant depression. Depression and anxiety 37 (9) (2020)
Jeffrey A Mills, Lu Lu, Tara S Peris, Amir Levine, John T Walkup
Research Review: Pediatric anxiety disorders - what have we learnt in the last 10 years? Journal of child psychology and psychiatry, and allied disciplines 62 (2) (2020)
Sian Cotton, Kristen M Kraemer, Richard W Sears, Jeffrey A Mills, Rachel S Wasson, Nina McCune, Jeffrey Welge, Thomas J Blom, Michelle Durling, Melissa P Delbello
Mindfulness-based cognitive therapy for children and adolescents with anxiety disorders at-risk for bipolar disorder: A psychoeducation waitlist controlled pilot trial. Early intervention in psychiatry 14 (2) (2019)
Jeffrey A Mills, Laura Geracioti, Neil Rajdev, Kelly Clemenza, Amir Levine
Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert opinion on pharmacotherapy 19 (10) (2018)
Jeffrey A Mills, Eric T Dobson
Individuation for a DSM-5 disorder: Adult separation anxiety. Depression and anxiety 34 (12) (2018)